P.A.S. SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do P.a.s. Sodium patents expire, and when can generic versions of P.a.s. Sodium launch?
P.a.s. Sodium is a drug marketed by Century Pharms and is included in one NDA.
The generic ingredient in P.A.S. SODIUM is aminosalicylate sodium. There is one drug master file entry for this compound. Additional details are available on the aminosalicylate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for P.A.S. SODIUM?
- What are the global sales for P.A.S. SODIUM?
- What is Average Wholesale Price for P.A.S. SODIUM?
Summary for P.A.S. SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 4,277 |
| Patent Applications: | 3,645 |
| DailyMed Link: | P.A.S. SODIUM at DailyMed |
Recent Clinical Trials for P.A.S. SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nextrast, Inc. | PHASE1 |
| Eurofarma Laboratorios S.A. | PHASE3 |
| Huashan Hospital | PHASE2 |
US Patents and Regulatory Information for P.A.S. SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Century Pharms | P.A.S. SODIUM | aminosalicylate sodium | POWDER;ORAL | 080947-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
